The Challenging Anticoagulant Therapy in COVID19 Patient with Associated Coagulopathy
COVID-19 became a widespread infectious disease in late 2019. Indonesia currently has the highest COVID-19 mortality rate in Asia, between 4-5 percent. Interestingly, COVID-19-associated coagulopathy characterized by an increase of several procoagulant factor levels, including fibrinogen and D-dimer...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Interna Publishing
2021-07-01
|
| سلاسل: | Acta Medica Indonesiana |
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://actamedindones.org/index.php/ijim/article/view/1606 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
